Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Intranasal parainfluenza virus type 5 (PIV5)-vectored RSV vaccine is safe and immunogenic in healthy adults in a phase 1 clinical study.
Sci Adv. 2023 Oct 27;9(43):eadj7611. doi: 10.1126/sciadv.adj7611. Epub 2023 Oct 25.
Sci Adv. 2023.
PMID: 37878713
Free PMC article.
Clinical Trial.
A parainfluenza virus 5 (PIV5)-vectored intranasal vaccine for Lyme disease provides long-lasting protection against tick transmitted Borrelia burgdorferi in mice.
Gingerich MC, Nair N, Azevedo JF, Samanta K, Kundu S, He B, Gomes-Solecki M.
Gingerich MC, et al.
Res Sq [Preprint]. 2023 Jul 18:rs.3.rs-3143132. doi: 10.21203/rs.3.rs-3143132/v1.
Res Sq. 2023.
PMID: 37503102
Free PMC article.
Updated.
Preprint.
Item in Clipboard
Intranasal vaccine for Lyme disease provides protection against tick transmitted Borrelia burgdorferi beyond one year.
Gingerich MC, Nair N, Azevedo JF, Samanta K, Kundu S, He B, Gomes-Solecki M.
Gingerich MC, et al.
NPJ Vaccines. 2024 Feb 15;9(1):33. doi: 10.1038/s41541-023-00802-y.
NPJ Vaccines. 2024.
PMID: 38360853
Free PMC article.
Item in Clipboard
Cite
Cite